Aelin Therapeutics SA

Dissolution volontaire – liquidation

Aelin Therapeutics reported revenue of 30,000 € for the 2025 financial year (annual accounts filed with the NBB on 10 Aug 2026).

By total assets for 2025, Aelin Therapeutics ranks among the 100 largest of the 1,785 companies in its sector (NACE 7499) in Belgium that filed accounts for that financial year. Largest companies in the sector →

Company number (CBE) 0685.688.842 · VAT BE0685688842
8200 Bruges
active in Other liberal professions and professional, scientific and technical activities n.e.c. (NACE 74999)
operating since 06 Dec 2017 (≈ 9 yrs)
Public Public page: latest year only. The score, history and details open with a free account. Create a free account
Idonis solidity score
EDCBA

The score of Aelin Therapeutics shows with a free account.

See the score
Profile
SA since 2017
Components
  • Summary? / 5
    • Balance sheet strength
    • Liquidity
    • Repayment capacity
    • Profitability
    • Trajectory
    • Compliance and register
  • Position in its sectorvs peers
  • Supplier creditat 30 d
  • Borrowing capacityborrowable
  • Valuationcentral

Visible once signed in: create your account, the 14-day Pro trial is free.

Detail

Key figures 2025

Revenue30,000 €
Net result313,335 €
Equity−€3.22m
Cash€1.80m
EBITDA−14 €
Total assets€2.10m
Solvency-153.6%
The line marks its sector median: 57.1% (1041 companies).

Change 2022 → 2025: Revenue +117 % Total assets -71 %

Accounts of the company itself (not consolidated).

The full file covers 8 financial years; a free account shows 2. →

Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error

Aelin Therapeutics's annual accounts

20252024202320222021
Revenue30,000 €
Net result313,335 €
Equity−€3.22m
Cash€1.80m
EBITDA−14 €
Total assets€2.10m

Filed annual accounts

  • Year ended 31 Dec 2025filed on 10 Aug 2026
  • Year ended 31 Dec 2024filed on 31 Oct 2025
  • Year ended 22 Jun 2023filed on 22 Dec 2023
  • Year ended 31 Dec 2022filed on 06 Jul 2023
  • Year ended 31 Dec 2021filed on 13 May 2022

Aelin Therapeutics's financial analysis

Management and control of Aelin Therapeutics

2 active director(s) in the register.

Aelin Therapeutics's shareholders and holdings →

Aelin Therapeutics's publications in the Belgian Gazette

Company number, VAT number and registered office

Company number (CBE)
0685.688.842
VAT number
BE0685688842
Peppol
Registered · 0208:0685688842 · as of 10 Nov 2026
Legal form
SA
Incorporated
06 Dec 2017
Registered office
8200 Bruges
Latest accounts
2025 · filed on 10 Aug 2026
Activity
Other liberal professions and professional, scientific and technical activities n.e.c. (NACE 74999)

Aelin Therapeutics (SA) has been based in Bruges since 2017, active in: other liberal professions and professional, scientific and technical activities n.e.c.. For 2025, it reports revenue of 30,000 €, a net profit of 313,335 € and equity of −€3.22m. Its solvency stands at -153.6%, below the median of its sector (57.1%).

Guide: Reading Belgian SME accounts: the five figures that count →

Companies similar to Aelin Therapeutics

Companies in the same business, of comparable size and area, outside its group.

Frequently asked questions about Aelin Therapeutics

What is the revenue of Aelin Therapeutics?

According to the 2025 annual accounts filed with the NBB, the revenue of Aelin Therapeutics amounts to 30,000 €.

What is the VAT number of Aelin Therapeutics?

In Belgium, the VAT number is the company number prefixed with BE: BE0685688842 for Aelin Therapeutics, if the company is VAT-registered. Its company number (CBE) is 0685.688.842.

Where is the registered office of Aelin Therapeutics?

According to the CBE register, the registered office of Aelin Therapeutics is in 8200 Bruges.

What is the equity of Aelin Therapeutics?

At the close of the 2025 financial year, the equity of Aelin Therapeutics amounts to -3,223,727 €, a solvency of -153.6% of total assets.

Who manages Aelin Therapeutics?

The register lists 2 active mandates at Aelin Therapeutics. Names and roles are in the full file, with the deeds published in the Belgian Gazette.

How large is Aelin Therapeutics within its sector?

By total assets for 2025, Aelin Therapeutics ranks among the 100 largest of the 1,785 companies in its sector (NACE 7499) in Belgium that filed accounts for that financial year.

Idonis

The full file of Aelin Therapeutics

Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.

Open the full file →
Free account in 30 seconds, by email. No bank card.
Sources : Annual accounts — NBB ↗ Register — CBE ↗ Deeds — Belgian Gazette ↗ · Updated on 12 Aug 2026

No credit card, no commitment.

What each plan unlocks →